To include your compound in the COVID-19 Resource Center, submit it here.

Roche finds active glucose control

A primary driver in the search for new pharmacological targets for diabetes is the goal of providing patients with better control over their glucose levels. Roche now reports that a small molecule activator targeting glucokinase, an enzyme believed to be important in regulating glucose homeostasis,

Read the full 456 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers